| 发明名称 |
TREATING MYELODYSPLASTIC SYNDROMES USING LENALIDOMIDE |
| 摘要 |
Methods of treating, preventing and/or managing myelodysplastic syndromes are disclosed. Specific methods encompass the administrations of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidin-2,6-dione in combination with 5-azacytidine. |
| 申请公布号 |
US2015038444(A1) |
申请公布日期 |
2015.02.05 |
| 申请号 |
US201414517280 |
申请日期 |
2014.10.17 |
| 申请人 |
Celgene Corporation |
发明人 |
Zeldis Jerome B. |
| 分类号 |
A61K31/706;A61K31/454 |
主分类号 |
A61K31/706 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a myelodysplastic syndrome, which comprises administering to a patient having a myelodysplastic syndrome a therapeutically effective amount of 5-azacytidine, and a therapeutically effective amount of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione or a pharmaceutically acceptable salt thereof. |
| 地址 |
Summit NJ US |
